MTHFR, DNA Analysis
A one-time genetic test for variants in the MTHFR enzyme, which converts folate into its active methylated form.
Explains stubbornly elevated homocysteine and guides which form of folate to supplement. Roughly 30–40% of people carry at least one variant, so this is common rather than exotic.
Which MTHFR variant did your report give?
What to do next. The genotype is not the finding — homocysteine is. Check it, and if it is raised, that is what you treat with methylfolate, B12, B6 and riboflavin. If homocysteine is normal on an ordinary diet, the variant is a curiosity rather than a problem, whatever the supplement marketing says. MTHFR has been oversold harder than almost anything in this space.
What MTHFR, DNA Analysis actually measures — the analyte, and the assay
This is a genotype, so there is no concentration, no interval and no retest. The test reports which base sits at two positions in the MTHFR gene: 677, where a cytosine-to-thymine change swaps alanine for valine, and 1298, where an adenine-to-cytosine change swaps glutamate for alanine. Each position has three possible results — two normal copies, one variant copy, or two variant copies.
The method is a targeted genotyping assay, not sequencing. Real-time PCR with allele-specific probes, or a mass-spectrometry-based single-nucleotide platform, interrogates those two positions and nothing else. It cannot find a rare pathogenic MTHFR variant, and it does not look.
What the variant does is measurable and modest. The 677 TT genotype produces a thermolabile enzyme with roughly 30% of normal activity in vitro; the CT heterozygote around 65%. That reduced activity raises homocysteine mainly when folate status is low, which is why folate fortification blunted the genotype's effect at a population level Long 2016.
Genotyping error is rare but not zero. Allele dropout from a polymorphism under a primer binding site is the classic mechanism, and it produces an apparent homozygote out of a heterozygote — which is one reason a surprising result is worth repeating on a fresh sample.
MTHFR, DNA Analysis: what changes the blood, and what only changes the reading
What changes the genotype: nothing. It was fixed at conception, it does not respond to diet, supplements or age, and any product marketed as addressing it is addressing the downstream biochemistry, not the gene.
What changes the biochemistry the genotype acts on:
- Folate intake and status, which is the dominant variable. With adequate folate, the 677 TT genotype's effect on homocysteine is small; with poor folate it is substantial Long 2016.
- Vitamin B12 and B6, the other two one-carbon cofactors.
- Riboflavin, which is the flavin cofactor for the MTHFR enzyme itself and matters more in TT homozygotes than in others.
- Kidney function, which sets homocysteine clearance independently of any of this.
- Recent food. One-carbon metabolites move measurably through the hours after a meal, which is why the downstream test is a fasting one Anfinsen 2023.
What changes only the report:
- Which two positions the laboratory tested. Panels that include only 677, only 1298, or both are all sold as MTHFR testing.
- How the result is presented. The same CT heterozygous result is reported as normal by one laboratory and as a mutation detected by another, which changes nothing biological and a great deal about how it reads Long 2016.
- Allele dropout, the rare technical false homozygote.
- Interpretive text supplied by a direct-to-consumer report, which is commentary rather than measurement.
Reference interval or decision threshold — which kind of number MTHFR, DNA Analysis is
Neither. A genotype has no reference interval and no decision threshold — it has allele frequencies. The 677 T allele is common: TT homozygosity runs at roughly 10–15% in many European and Hispanic populations and lower in others. A finding present in one person in eight is a population variant, not a diagnosis.
The professional position is unusually blunt. The American College of Medical Genetics and Genomics published a practice guideline titled around the lack of evidence for MTHFR polymorphism testing Hickey 2013, and reaffirmed it in a formal addendum in 2020 Bashford 2020. Very few laboratory tests on this site have a specialty college recommending against them by name.
The reasoning is causal, not merely economic. The genotype's only established mechanism runs through homocysteine; homocysteine can be measured directly and cheaply; and lowering homocysteine has not reduced cardiovascular events in randomized trials Marti-Carvajal 2017. Mendelian randomization — which is, in effect, a natural experiment on this exact genotype — pointed the same way Yuan 2021.
That last point deserves emphasis, because it is the genotype testing itself. Mendelian randomization studies use MTHFR variants as the instrument for lifelong homocysteine exposure. If the genotype mattered clinically, that design would show it Yuan 2021.
How you would know your MTHFR, DNA Analysis was wrong — and when to redraw
Never. A genotype does not change, and a second test on the same person is a test of the laboratory. The only reason to repeat is a result that contradicts a family pattern, where allele dropout is the hypothesis being tested.
What does have a retest interval is the biochemistry. Homocysteine responds to B-vitamin repletion within weeks, and the red cell folate that confirms it takes about 120 days to re-equilibrate.
Conditions that must match for the downstream test: a fasting sample Anfinsen 2023; prompt centrifugation; the same laboratory; and stable kidney function.
What would have to change for the genotype to mean anything:
- Carrying 677 TT? The measurement that decides whether it matters in you is homocysteine. A normal homocysteine on a fasting, properly handled sample means the enzyme is being adequately supported, whatever the genotype says.
- Homocysteine raised? Then the useful tests are folate, vitamin B12 and creatinine with eGFR in the CMP — the three things that actually determine it Marti-Carvajal 2017.
- Homocysteine normal? The genotype has no further consequence to investigate, and nothing follows from it Hickey 2013.
- Told the genotype explains fatigue, mood or miscarriage? The ACMG guideline and its addendum address those claims specifically and find the evidence lacking Hickey 2013 Bashford 2020.
What MTHFR, DNA Analysis cannot tell you
It cannot tell you your homocysteine. The genotype accounts for a minority of the variance, and folate, B12 and renal function account for most of it Long 2016.
It cannot predict thrombosis. The ACMG guideline addresses MTHFR testing in thrombophilia workups directly and recommends against it Hickey 2013 Bashford 2020.
It cannot indicate which form of folate anybody needs. No trial has shown a genotype-dependent advantage of one folate form over another on a clinical outcome.
It cannot explain a symptom. A variant present in a large fraction of the healthy population cannot be the explanation for an individual's symptoms without a measurement connecting the two.
The wrong inference readers actually draw is that a variant here is a defect requiring lifelong correction. The measurable consequence is a homocysteine level; the homocysteine can be measured for less than the genotype costs; and lowering it has not changed outcomes in randomized trials Marti-Carvajal 2017 Yuan 2021 Hickey 2013.
Sources read for these sections
- Hickey SE, et al. ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing. Genetics in Medicine 2013 · PMID 23288205
- Bashford MT, et al. Addendum: ACMG Practice Guideline: lack of evidence for MTHFR polymorphism testing. Genetics in Medicine 2020 · PMID 32533132
- Long S, et al. MTHFR genetic testing: Controversy and clinical implications. Australian Family Physician 2016 · PMID 27052143
- Marti-Carvajal AJ, et al. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database of Systematic Reviews 2017 · PMID 28816346
- Yuan S, et al. Homocysteine, B vitamins, and cardiovascular disease: a Mendelian randomization study. BMC Medicine 2021 · PMID 33888102
- Anfinsen AM, et al. Time-resolved concentrations of serum amino acids, one-carbon metabolites and B-vitamin biomarkers during the postprandial and fasting state: the Postprandial Metabolism in Healthy Young Adults (PoMet) Study. British Journal of Nutrition 2023 · PMID 37886826
The plan of attack
In this order. Most people start at step four, which is why they change five things at once and learn nothing.
- Confirm the number is real
Nothing physiological affects this result. Your genotype is fixed. No fasting state, illness, supplement or medication changes it, and a repeat returns the same answer — worth saying plainly rather than leaving this section blank. Test once and never repeat it. Spend the money on the functional marker instead. - Read it with its partner
The practical value is in what it tells you to supplement. MTHFR status is widely over-interpreted online — it's a useful data point, not an explanation for everything. Draw it alongside: Homocysteine, Folate, Serum, Vitamin B12. - Work out which direction is yours
If it's high — Homozygous C677T reduces enzyme efficiency substantially and is associated with higher homocysteine.
If it's low — Normal function. - Fix it in this order
Nutrition. Leafy greens and legumes for natural folate. Some carriers do better avoiding synthetic folic acid in fortified foods and supplements in favor of methylfolate.
Lifestyle. Avoid smoking and excess alcohol, both of which further burden methylation.
Supplements. Methylfolate (5-MTHF) instead of folic acid, plus methylcobalamin B12 and P5P (B6). Add riboflavin — it's the cofactor for MTHFR and specifically helps C677T carriers. TMG/betaine provides an alternate methylation route.
Hormones. No hormonal intervention. Relevant preconception — discuss folate dosing with a provider.
Compounds. No peptide interaction.
Work down the list, not across it. Adding a compound on top of an unfixed diet is why generic protocols fail. - Retest
Never — fixed for life. Change one thing at a time, or the retest can't tell you which thing worked.
How to fix it
📚 Frosst P et al., Nat Genet 1995 — MTHFR C677T. Homocysteine Studies Collaboration, JAMA 2002.
This page can tell you what could have made your MTHFR, DNA Analysis wrong. It cannot tell you whether it did.
Everything above is free and stays free — the assay, what changes the reading rather than the blood, the retest window and the sources. What no page can do is look at your draw: which laboratory ran it, at what hour, what you were taking that week, and what else was flagged beside it. Every one of those changes the answer, and none of them is on any page. Bringing a real result to people who know that list is what the members' area is for.
Bring your result — $10/mo →🩸 Test your MTHFR, DNA Analysis
Order directly through Marek Diagnostics — no doctor's visit needed, drawn at any Quest location in the US. Code CAMERON applies 10% off automatically.
Order this test — 10% off → Browse all 103 markers →What MTHFR, DNA Analysis is usually tested alongside
One marker is a data point. These panels add the markers that make MTHFR, DNA Analysis interpretable, name why each is on the list, and load the set into your cart at 10% off.
includes this + 4 more markers — You want the handful of genetic results that actually change what you do — tested once, never repeated.
What people use MTHFR, DNA Analysis to decide
Nobody orders a test for its own sake. MTHFR, DNA Analysis is on the test list for these pathways — each one links to what the pathway claims, and what its test list is read for before you spend anything on it.
How you metabolize estrogen matters as much as how much you make, and the methylation step depends on COMT having the methyl groups to work with. Homocysteine is the read on that.
Raised homocysteine is the single best functional read on whether the methylation cycle is running. This is the pathway behind most treatment-resistant low mood that responds to nothing else, and the whole workup costs less than a month of supplements.
Conjugation runs on amino acids, methyl groups and minerals. Homocysteine is the functional read on whether the methylation arm is working — upregulating Phase I with Phase II short produces more reactive intermediates than you started with.
What moves your MTHFR, DNA Analysis
1 supplement in the Vault have a documented effect on this marker, or are a reason to have measured it first:
Browse all 278 compounds & 371 supplements →
Would you feel it? Symptoms MTHFR, DNA Analysis helps explain
People search for how they feel, not for a marker. These are the complaints where this one is worth checking, and whether it is first-line or a follow-up.
Why your MTHFR, DNA Analysis might be wrong
Most abnormal results are interference, not disease. Check these before you change anything. Each says whether the number is wrong (repeat it), badly timed (redraw it), or real with a cause.
Your genotype is fixed. No fasting state, illness, supplement or medication changes it, and a repeat returns the same answer — worth saying plainly rather than leaving this section blank.
Test once and never repeat it. Spend the money on the functional marker instead.
MTHFR variants are extremely common — roughly a quarter of some populations carry two copies of C677T. Carrying a variant is close to unremarkable, and large studies have not shown the sweeping consequences attributed to it online.
Homocysteine is the functional test that actually matters. A normal homocysteine with an MTHFR variant means the pathway is working. Treat the number, not the genotype.
Different tests cover different variants. A report saying 'MTHFR negative' may simply not have assayed the variant you carry.
Check which variants were actually tested.
What MTHFR, DNA Analysis means in combination
One marker tells you a little; combinations tell you the story. These are the named patterns this one takes part in.
The pathway is working. MTHFR variants are extremely common — around a quarter of some populations carry two copies — and carrying one is close to unremarkable. Homocysteine is the functional readout, and a normal one says the genotype is not causing you a problem.
Treat the number, not the genotype. If homocysteine is raised, correct B12 and folate — with B12 first, always, because folate can normalize the anemia while nerve damage continues.
What to test next
These put MTHFR, DNA Analysis in context — each with its own full breakdown.
Frequently asked questions
Result: normal, heterozygous, or homozygous for C677T and/or A1298C. Ranges vary by laboratory and assay — always compare to the range printed on your own report.
No variants. Carrying a variant is common and manageable — not a diagnosis.
Homozygous C677T reduces enzyme efficiency substantially and is associated with higher homocysteine.
Normal function.
You can order MTHFR, DNA Analysis directly through Marek Diagnostics without a doctor's visit — drawn at any Quest Diagnostics location in the US. Code CAMERON applies 10% off automatically.
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.